semaglutide compounding fda enforcement today New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our compounding semaglutide enforcement news today

Available from: FDA (2024): Multi-Discipline Review for neffy (epinephrine nasal spray), NDA 214697

Losing fat while preserving muscle produces better long-term outcomes than indiscriminate weight loss

PlexusDx provides compounded semaglutide injections ($189/mo), oral semaglutide ($289/mo month-to-month, or from $249/mo on the 6-month plan), compounded tirzepatide injections ($289/mo), and oral tirzepatide ($349/mo) through licensed 503A pharmacies

JOE ROGAN: Didnt some lady take that

Sex-dependent effects emerged specifically in a large Korean study with anxious population, where men exhibited reduced alpha diversity while women showed no changes (Kim et al., 2023)

These can include a reduction in appetite and an increased feeling of fullness after meals